Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Banerji · SciRah

Researcher profile · Semantic Scholar

V. Banerji

Share profile

V. Banerji — researcher profile on SciRah

h-index: 24
Works: 140
Citations: 2,689

Most-cited papers

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
J. Sharman, M. Egyed, W. Jurczak, A. Skarbnik +25 more
2020The Lancet541 citations Open access
Semantic Scholar
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
M. Grever, O. Abdel-Wahab, L. Andritsos, V. Banerji +37 more
2017Blood254 citations Open access
Semantic Scholar
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
J. Sharman, M. Egyed, W. Jurczak, A. Skarbnik +23 more
2022Leukemia172 citations Open access
Semantic Scholar
ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL).
J. Sharman, V. Banerji, L. Fogliatto, Y. Herishanu +24 more
2019Blood64 citations Open access
Semantic Scholar
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN
Jeff P. Sharman, M. Egyed, W. Jurczak, A. Skarbnik +23 more
2025Blood55 citations Open access
Semantic Scholar
Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN
J. Sharman, M. Egyed, W. Jurczak, A. Skarbnik +23 more
2023Blood48 citations Open access
Semantic Scholar
Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration
Ahmed Y. Ali, Xun Wu, N. Eissa, Sen Hou +7 more
2018Leukemia48 citations Open access
Semantic Scholar
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group
M. Seftel, J. Kuruvilla, T. Kouroukis, V. Banerji +15 more
2017Leukemia and Lymphoma40 citations
Semantic Scholar
Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts
Edgard M. Mejia, Hana M. Zegallai, Eric D. J. Bouchard, V. Banerji +2 more
2018Journal of Biological Chemistry34 citations Open access
Semantic Scholar
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
M. Grever, L. Andritsos, V. Banerji, J. Barrientos +35 more
2021Leukemia33 citations Open access
Semantic Scholar
Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
S. R. Roy Chowdhury, V. Banerji
2018Oxidative Medicine and Cellular Longevity33 citations Open access
Semantic Scholar
An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring
Rebecca Starkman, S. Alibhai, R. Wells, M. Geddes +22 more
2019Leukemia32 citations
Semantic Scholar
Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival
G. Ishdorj, S. Beiggi, Z. Nugent, Erin Streu +7 more
2019Leukemia and Lymphoma29 citations
Semantic Scholar
IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.
G. Ishdorj, Erin Streu, P. Lambert, Harbhajan Dhaliwal +5 more
2019Blood Advances27 citations Open access
Semantic Scholar
Natural History of Monoclonal B-cell Lymphocytosis (MBL) Among Relatives in Chronic Lymphocytic Leukemia (CLL) Families.
S. Slager, Mark C. Lanasa, Gerald E. Marti, S. Achenbach +24 more
2020Blood25 citations Open access
Semantic Scholar
EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells
Cornelia N. Mutz, Raphaela Schwentner, D. Aryee, Eric D. J. Bouchard +9 more
2017OncoTarget25 citations Open access
Semantic Scholar
Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN.
J. Sharman, M. Egyed, W. Jurczak, A. Skarbnik +15 more
2022Journal of Clinical Oncology24 citations
Semantic Scholar
Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia
Xun Wu, J. E. Fajardo-Despaigne, Christina R. Zhang, V. Neppalli +4 more
2021Frontiers in Oncology24 citations Open access
Semantic Scholar
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
F. Ravandi, R. Kreitman, E. Tiacci, L. Andritsos +41 more
2022Blood Cancer Journal23 citations Open access
Semantic Scholar
Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Elevate-TN four-year follow up.
J. Sharman, M. Egyed, W. Jurczak, A. Skarbnik +16 more
202119 citations
Semantic Scholar
Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment
S. R. Roy Chowdhury, Eric D. J. Bouchard, R. Saleh, Z. Nugent +16 more
2020Cancers19 citations Open access
Semantic Scholar
Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma
E. Martell, H. Kuzmychova, E. Kaul, H. Senthil +10 more
2023Nature Communications18 citations Open access
Semantic Scholar
Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update.
C. Owen, V. Banerji, Natalie Johnson, A. Gerrie +3 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis17 citations Open access
Semantic Scholar
Associations between statin use and risk of non‐Hodgkin lymphomas by subtype
Xi-Biao Ye, Geng Zhang, C. Righolt, J. Johnston +3 more
2018International Journal of Cancer16 citations Open access
Semantic Scholar
Revised 15-item MDS-specific frailty scale maintains prognostic potential
B. A. Wan, A. Nazha, Rebecca Starkman, S. Alibhai +24 more
2020Leukemia14 citations
Semantic Scholar
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry
R. Buckstein, L. Chodirker, K. Yee, M. Geddes +16 more
2023Leukemia and Lymphoma13 citations Open access
Semantic Scholar
Descriptive analysis of dosing and outcomes for patients with ibrutinib-treated relapsed or refractory chronic lymphocytic leukemia in a Canadian centre.
K. Uminski, K. Brown, O. Bucher, I. Hibbert +5 more
2019Current Oncology13 citations Open access
Semantic Scholar
Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis
N. Epperla, Qiu-Hong Zhao, M. Anghelina, Jasmine Neal +9 more
2023American journal of hematology/oncology12 citations Open access
Semantic Scholar
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
M. Grever, Leslie A Andritsos, M. Anghelina, E. Arons +41 more
2024Leukemia11 citations Open access
Semantic Scholar
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
Jennifer Teichman, M. Geddes, N. Zhu, M. Keating +21 more
2022Haematologica11 citations Open access
Semantic Scholar
Statin Use and Chronic Lymphocytic Leukemia Incidence: A Nested Case–Control Study in Manitoba, Canada
C. Righolt, Geng Zhang, Xi-Biao Ye, V. Banerji +3 more
2019Cancer Epidemiology, Biomarkers and Prevention11 citations
Semantic Scholar
Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
J. Lachaine, K. Guinan, A. Aw, V. Banerji +2 more
2023Current Oncology10 citations Open access
Semantic Scholar
Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study
I. Amitai, M. Geddes, N. Zhu, M. Keating +21 more
2021British Journal of Haematology10 citations Open access
Semantic Scholar
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
J. Lachaine, C. Beauchemin, K. Guinan, P. Thebault +4 more
2021Current Oncology10 citations Open access
Semantic Scholar
Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine.
Anamarija M. Perry, K. Matsuda, V. Wadhwa, D. Hewitt +3 more
2017Blood Advances10 citations Open access
Semantic Scholar
Bruton tyrosine kinase inhibitors for the frontline treatment of chronic lymphocytic leukemia.
V. Banerji, A. Aw, S. Robinson, S. Doucette +2 more
2020Current Oncology9 citations Open access
Semantic Scholar
Metformin Is Not Associated with Incidence Risk of Non-Hodgkin Lymphomas among Diabetic Patients
Xi-Biao Ye, Geng Zhang, C. Righolt, J. Johnston +3 more
2018Cancer Epidemiology, Biomarkers and Prevention9 citations
Semantic Scholar
Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia.
C. Owen, A. Gerrie, V. Banerji, S. Assouline +4 more
2018Current Oncology9 citations Open access
Semantic Scholar
Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia
Nicole Bourrier, Ivan Landego, O. Bucher, M. Squires +8 more
2022BMC Cancer8 citations Open access
Semantic Scholar
Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment.
Xun Wu, Jordan Thisdelle, Sen Hou, J. E. Fajardo-Despaigne +5 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis7 citations
Semantic Scholar
Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia.
C. Owen, Sarah Eisinga, V. Banerji, Natalie Johnson +4 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis7 citations Open access
Semantic Scholar
PD-1 inhibition in malignant melanoma and lack of clinical response in chronic lymphocytic leukemia in the same patients: a case series.
Ivan Landego, D. Hewitt, I. Hibbert, Dhali H. S. Dhaliwal +5 more
2020Current Oncology7 citations Open access
Semantic Scholar
A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome
Antoine Wagner, M. Rouleau, L. Villeneuve, T. Le +11 more
2023Cells6 citations Open access
Semantic Scholar
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry
R. Buckstein, L. Chodirker, L. Mozessohn, K. Yee +22 more
2022Leukemia and Lymphoma6 citations Open access
Semantic Scholar
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia
S. Assouline, L. Amrein, R. Aloyz, V. Banerji +13 more
2020Leukemia and Lymphoma5 citations
Semantic Scholar
Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow
Ahmed Y. Ali, Q. Guan, Xun Wu, Sen Hou +6 more
2019British Journal of Haematology5 citations
Semantic Scholar
Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
S. Kost, A. Saleh, Edgard M. Mejia, Marina Mostafizar +6 more
2019Cancers5 citations Open access
Semantic Scholar
Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant.
C. Zent, E. Tiacci, Robert J. Kreitman, Tamar Tadmor +43 more
2026Blood4 citations Open access
Semantic Scholar
Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System
Christopher Lemieux, Chai W. Phua, K. Robinson, Carolyn Owen +1 more
2025Current Oncology4 citations Open access
Semantic Scholar
Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines.
G. Ishdorj, Z. Nugent, M. Squires, S. Kost +6 more
2021Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Johnston×18
Invite
J. Johnston — researcher profile on SciRah
S. Gibson×14
Invite
S. Gibson — researcher profile on SciRah
A. Marshall×9
Invite
A. Marshall — researcher profile on SciRah
M. Egyed×7
Invite
M. Egyed — researcher profile on SciRah

×7

Invite

M. Kamdar — researcher profile on SciRah

Y. Herishanu×7

Invite

Y. Herishanu — researcher profile on SciRah

Invite

P. Ghia — researcher profile on SciRah

Invite

J. Sharman — researcher profile on SciRah

Invite

A. Skarbnik — researcher profile on SciRah

Invite

T. Munir — researcher profile on SciRah

L. Fogliatto×6

Invite

L. Fogliatto — researcher profile on SciRah

Invite

K. Karlsson — researcher profile on SciRah